Category Archives: Biotechnology

1st Biotechnology World Symposium CIBA-IPN El 1st Biotechnology World Symposium y 9 Encuentro Nacional de Biotecnologa del IPN, se llevar cabo del 13 al 16 de octubre en el CIBA, Unidad Tlaxcala. In... By: ConversusTV … Continue reading →

Listen as Kraft Admits GMOs'Our Products Enhanced with Biotechnology' By: alex jones Jones … Continue reading →

From the oil industry to the pharmaceutical sector, biotechnology is now emerging as an indispensable element of Research & Development at the worlds leading companies. The term biotechnology started to become widespread in the 1980s when it first became feasible to transfer genetic information from one living system to another. Speaking at the Biotechnologies session of the Innovation Connecting Show (ICS) which took place on 16-18 September in the French city of Toulouse, Pierre Monsan, founder of the Toulouse White Biotechnology research centre, recalled how in the early 2000s it became increasingly possible for small laboratories to sequence the human genome. Todays synthetic biology differs in its methodology, but it has not deviated from the basic principle: acting on living organisms by manipulating their genetic make-up. Pierre Monsan told the ICS audience that the two major areas of biotechnology research today are the field of applied medicine, mainly with a view to treating cancerous cells, and also the energy sector. On the medical front, one example is how biotechnology specifically DNA sequencing is central to the work being done by researchers at Massachusetts-based clinical stage biopharmaceutical company Epizyme to analyse the different types of cancer. In general terms, we can … Continue reading →

Returned from UK with MSc, biotech student finally found dream job in India! Shimme Sharma is a small town girl from Kharagpur with great aspirations in life. She graduated from Birla Institute of Technology, Mesra, India in Biotechnology. Unable to find career opportunitie... By: Iipta PR … Continue reading →

TWAS DBT Postgraduate Fellowship Programme in Biotechnology, India TWAS DBT Postgraduate Fellowship Programme in Biotechnology, India. By: Examsavvy … Continue reading →

Healthcare And Biotechnology Financing Firm - Celadon Capital Finding the right venture capital firm for finance healthcare and biotechnology without any problem. Celadon Capital is the best option to all over Asia-Pacific. Call us at 60-3 2711-7211.... By: Celadon Asia … Continue reading →

MSc Microbiology and Biotechnology Andrew Patterson VT3106. By: Leeds Beckett University … Continue reading →

Night lab from National Center for Biotechnology, Astana Kazakhstan Night lab made by National Center for Biotechnology, Astana Kazakhstan Video made for the Competition The Art of Shaking operated by Kuhner Shaker http://www.kuhner... By: The Art of Shaking by Kuhner Shaker … Continue reading →

UTS Science in Focus: Microalgae - The green gold of biotechnology This is UTS Science TEDx style! Three short, sharp talks by three of the smartest thinkers at UTS. Topics include microalgae as a renewable energy source, how the brain destroys itself and... By: University of Technology, Sydney … Continue reading →

By Susan J. Aluise, Aviation, Auto & Transportation Writer Just when we thought the biotechnology rally was taking a breather, many biotech stocks got a second wind and thats good news for growth investors. Gaining exposure to the biotechnology sector makes sense for most investors but the big question isnt whether you play the biotech boom, but how you play it. PLUS: Kellogg - Boring-but-Awesome Dividend Stock Lets be clear: biotech stocks are the epitome of volatile, high-beta securities. While the NASDAQ Biotechnology Index is up 18% year-to-date, it has been a wild ride: up 21% from January to late February, down 21% from February to mid-April and up 24% since then. Why do biotech stocks suffer such extreme fits and starts? Simply put, biotechnology is a big bet on highly promising, but extremely uncertain, new treatments created from living organisms like viruses, bacteria, DNA or other molecules. The lions share of biotech drugs flame out in early-stage testing and only 40% of the drugs that clear the final stage of testing receive FDA approval. That said, here are three hot ways to play the surging biotechnology sector now: An individual biotech stock, an exchange-traded fund (ETF) and a mutual … Continue reading →